COMMUNIQUÉS West-GlobeNewswire

CRISPR Therapeutics Announces Transition of Bill Lundberg, MD

08/02/2018 - 22:30

ZUG, Switzerland and CAMBRIDGE, Mass., Feb. 08, 2018 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP ), a biopharmaceutical company focused on developing transformative gene-based medicines for serious diseases, [...]

The Ensign Group Reports Fourth Quarter and Fiscal Year 2017 Results

08/02/2018 - 22:19

MISSION VIEJO, Calif., Feb. 08, 2018 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG ), the parent company of the Ensign™ group of skilled nursing, rehabilitative care services, home health, home care, hospice [...]

The Cooper Companies Announces Release Date for First Quarter 2018

08/02/2018 - 22:15

PLEASANTON, Calif., Feb. 08, 2018 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE: COO ) today announced it will release first quarter 2018 financial results on Thursday, March 8, 2018, at 4:15 PM ET. Following the [...]

Immunomedics Announces Second Quarter Fiscal 2018 Results and Provides Corporate Update

08/02/2018 - 22:15

Presented Compelling Results with Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer (mTNBC) at San Antonio Breast Cancer Symposium Secured $250 Million Funding to Support Company’s Next Growth Phase [...]

Ascendis Pharma A/S Announces Participation in Leerink Partners 7th Annual Global Healthcare Conference

08/02/2018 - 22:15

COPENHAGEN, Denmark, Feb. 08, 2018 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND ), a biopharmaceutical company that utilizes its innovative TransCon technology to address significant unmet medical needs in rare [...]

Five Prime Therapeutics to Present at LEERINK Partners 7th Annual Global Healthcare Conference

08/02/2018 - 22:10

SOUTH SAN FRANCISCO, Calif., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Five Prime Therapeutics, Inc . (Nasdaq: FPRX ), a biotechnology company discovering and developing innovative immuno-oncology protein therapeutics, today [...]

Fluidigm Announces Fourth Quarter and Full Year 2017 Financial Results and Operational Progress

08/02/2018 - 22:05

Fluidigm Posts Sequential and Year-Over-Year Quarterly Revenue Growth 2017 Highlights Include Launch of Hyperion Imaging System, Licensing and Distribution Partnerships, Improved Balance Sheet, Double-Digit Operating [...]

ImmuCell Announces Preliminary Financial Results for Fourth Quarter and Full Year 2017

08/02/2018 - 22:05

PORTLAND, Maine, Feb. 08, 2018 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC ) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically-proven and [...]

Organovo Announces Fiscal Third-Quarter 2018 Results; Company Updates Full-Year Fiscal 2018 Outlook

08/02/2018 - 22:05

SAN DIEGO, Feb. 08, 2018 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ: ONVO ) (“Organovo”) today reported financial results for the fiscal third quarter of 2018 and updated its full-year fiscal 2018 outlook. The [...]

Corium Reports First Quarter Fiscal 2018 Financial Results and Corporate Highlights

08/02/2018 - 22:03

MENLO PARK, Calif., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq: CORI ), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty [...]

Relievant Announces Publication of Positive Outcomes in 12-Month SMART Sham RCT

08/02/2018 - 22:03

SUNNYVALE, Calif., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Relievant Medsystems, a privately held medical device company that developed the Intracept® Procedure, a minimally invasive and clinically proven approach for the [...]

Dermira Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

08/02/2018 - 22:01

MENLO PARK, Calif., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ: DERM ), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies [...]

Editas Medicine to Participate in Upcoming Investor Conferences

08/02/2018 - 22:01

CAMBRIDGE, Mass., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ: EDIT ), a leading genome editing company, today announced that it will participate in two upcoming investor conferences. Details are as [...]

Zafgen to Present at the Leerink Partners 7th Annual Global Healthcare Conference

08/02/2018 - 22:00

BOSTON, Feb. 08, 2018 (GLOBE NEWSWIRE) -- Zafgen, Inc. (Nasdaq: ZFGN ), a clinical-stage biopharmaceutical company leveraging its proprietary knowledge of MetAP2 systems biology to develop novel therapies for patients [...]

Doctor brings exercise as medicine trend to Toronto

08/02/2018 - 20:55

TORONTO, Feb. 08, 2018 (GLOBE NEWSWIRE) -- A Toronto doctor and his partner have launched Toronto’s first medical fitness clinic catering to boomers suffering from the chronic diseases that come with aging and a [...]

Abeona Therapeutics Reports Top-Line Data from Phase 1/2 Gene Therapy Trial in MPS IIIA

08/02/2018 - 20:00

ABO-102 results presented at WORLDSymposium for Lysosomal Diseases show significant time- and dose-dependent reduction of underlying disease pathology, including decreased CSF and urine GAGs (HS fragments) and [...]

ProCare Pain Solutions Welcomes New President

08/02/2018 - 20:00

MELVILLE, N.Y., Feb. 08, 2018 (GLOBE NEWSWIRE) -- ProCare Pain Solutions , a division of North American Partners in Anesthesia (NAPA), is pleased to announce that Michael Lemonds has joined ProCare as president. Mr. [...]

IBA SA : IBA - TRANSPARENCY NOTIFICATION

08/02/2018 - 18:00

IBA - TRANSPARENCY NOTIFICATION Louvain-la-Neuve, Belgium, February 08, 2018, 17.35 - IBA (Ion Beam Applications SA), the world's leading provider of proton therapy solutions for the treatment of cancer, announces that [...]

IBA SA : IBA - NOTIFICATION DE TRANSPARENCE

08/02/2018 - 18:00

IBA - NOTIFICATION DE TRANSPARENCE Louvain-la-Neuve, Belgique, 08 février 2018, 17.35 - IBA (Ion Beam Applications SA), le premier fournisseur mondial de solutions de protonthérapie pour le traitement du cancer, annonce [...]